TIAA CREF Investment Management’s Emergent Biosolutions EBS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$5.49M	Sell	108,720 -34,390	-24%	-$2.03M	﹤0.01%	1380
2018 Q4	$8.48M	Sell	143,110 -65,043	-31%	-$4.19M	0.01%	1032
2018 Q3	$13.7M	Sell	208,153 -1,183	-0.6%	-$69K	0.01%	942
2018 Q2	$10.6M	Sell	209,336 -24,027	-10%	-$1.25M	0.01%	1124
2018 Q1	$12.3M	Buy	233,363 +64,893	+39%	+$3.23M	0.01%	998
2017 Q4	$7.83M	Buy	168,470 +81,125	+93%	+$3.41M	0.01%	1295
2017 Q3	$3.53M	Sell	87,345 -2,754	-3%	-$99.6K	﹤0.01%	1838
2017 Q2	$3.06M	Buy	90,099 +933	+1%	+$28.8K	﹤0.01%	1910
2017 Q1	$2.59M	Sell	89,166 -5,220	-6%	-$159K	﹤0.01%	1980
2016 Q4	$3.1M	Sell	94,386 -5,336	-5%	-$160K	﹤0.01%	1932
2016 Q3	$3.14K	Sell	99,722 -1,445	-1%	-$42K	﹤0.01%	1903
2016 Q2	$2.85M	Buy	101,167 +282	+0.3%	+$11.1K	﹤0.01%	1916
2016 Q1	$3.67M	Sell	100,885 -5,866	-5%	-$207K	﹤0.01%	1707
2015 Q4	$4.27M	Sell	106,751 -12,774	-11%	-$445K	﹤0.01%	1665
2015 Q3	$3.4M	Sell	119,525 -5,542	-4%	-$183K	﹤0.01%	1811
2015 Q2	$4.12M	Buy	125,067 +6,014	+5%	+$186K	﹤0.01%	1817
2015 Q1	$3.42M	Sell	119,053 -702	-0.6%	-$20.1K	﹤0.01%	1885
2014 Q4	$3.26M	Sell	119,755 -10,986	-8%	-$262K	﹤0.01%	1929
2014 Q3	$2.79M	Sell	130,741 -31,382	-19%	-$719K	﹤0.01%	2006
2014 Q2	$3.64M	Sell	162,123 -16,461	-9%	-$383K	﹤0.01%	1907
2014 Q1	$4.51M	Sell	178,584 -2,980	-2%	-$75.3K	﹤0.01%	1703
2013 Q4	$4.17M	Sell	181,564 -7,131	-4%	-$149K	﹤0.01%	1771
2013 Q3	$3.6M	Sell	188,695 -12,306	-6%	-$220K	﹤0.01%	1824
2013 Q2	$2.9M	Buy	+201,001	New	+$2.91M	﹤0.01%	1918